Atlas Trials

Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)

Clinical trial NCT01315847 · COMPLETED

Trial details

NCT number
NCT01315847
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2010-01-14
Primary completion
2011-07-26
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.